Polypharmacy in Heart Failure: Progress But Also Problem
- PMID: 34051153
- PMCID: PMC10326723
- DOI: 10.1016/j.amjmed.2021.05.007
Polypharmacy in Heart Failure: Progress But Also Problem
Conflict of interest statement
Figures
Comment on
-
Polypharmacy in Heart Failure with Reduced Ejection Fraction: Progress, Not Problem.Am J Med. 2021 Sep;134(9):1068-1070. doi: 10.1016/j.amjmed.2021.03.038. Epub 2021 May 1. Am J Med. 2021. PMID: 33939999 Free PMC article. No abstract available.
References
-
- Yancy CW, Jessup M, Bozkurt B, et al. 2017 ACC/AHA/HFSA focused update of the 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America. J Am Coll Cardiol 2017;70(6):776–803. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
